TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Trulieve Cannabis Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$10.28+0.27 (+2.70%)
Close on Oct 19, 2026
- Market cap
- $1.98B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$2.60 (+33.85%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Trulieve Cannabis Corp. saw revenue fall 3.9% to $1.14B over the twelve months to Jun 30, 2026. Operating income fell 415.5% to -$277.26M, moving the operating margin from 7.4% to -24.3%. Free cash flow was $202.56M, up 151.3% from a year earlier.
Revenue
$1.14B
-3.9% vs. a year earlier
Operating income
-$277.26M
-415.5% vs. a year earlier
Free cash flow
$202.56M
+151.3% vs. a year earlier
EPS, diluted
-$2.46
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.98B
- P/E ratio
- –
- Price to sales
- 1.74
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 10.22%
Fundamentals
- Revenue
- $1.14B
- EPS, diluted
- -$2.46
- Free cash flow
- $202.56M
- Diluted shares
- 193M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$1.14B-3.9% YoY
Gross profit
$677.39M-6.8% YoY
Operating income
-$277.26M-415.5% YoY
Net income
–
EPS, diluted
-$2.46
Free cash flow
$202.56M+151.3% YoY
Reported periodTrailing twelve months